Pharming Group N.V. announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025.

Pharming Group N.V. today announced the appointment of Kenneth Lynard as Chief Financial Officer (CFO), effective October 1, 2025.

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of August:

Pharming Group N.V. presents its preliminary (unaudited) financial report for the second quarter and first half year ended June 30, 2025.

Pharming Group N.V. confirms that it will report its preliminary (unaudited) financial results for the second quarter and first half 2025 and provide a business update on Thursday, July 31, 2025.

For media and investors only

Pharming Group N.V. announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved.

Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:

Pharming Group N.V. presents its preliminary unaudited financial report for the three months ended March 31, 2025.

Pharming Group N.V. announces that the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”) will be held on Wednesday June 11, 2025, at 14:00 CEST.